Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Current Taxes (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Current Taxes came in at $1.1 billion in Q2 2026, down 36.88% year-over-year from $1.7 billion in Q2 2025, and down 3.31% quarter-over-quarter from $1.1 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Current Taxes (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Current Taxes across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

  • In Q2 2026, Current Taxes fell 36.88% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (down 36.88% YoY), while the FY2025 annual figure was $1.4 billion, down 63.2% from the prior year.
  • Current Taxes came in at $1.1 billion for Q2 2026 at Johnson & Johnson, down from $1.1 billion in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $4.8 billion in Q3 2024 to a low of $1.1 billion in Q2 2026.
  • Average Current Taxes over 5 years is $2.6 billion, with a median of $2.2 billion recorded in 2023.
  • Year-over-year, Current Taxes soared 149.77% in 2023 and plunged 74.22% in 2026.
  • Over 5 years, Current Taxes stood at $2.0 billion in 2022, then soared by 50.7% to $3.0 billion in 2023, then climbed by 26.03% to $3.8 billion in 2024, then tumbled by 63.2% to $1.4 billion in 2025, then fell by 24.28% to $1.1 billion in 2026.
  • Per Business Quant data, the three most recent Current Taxes figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.4 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 1.05 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 2.31 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 653.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 1.03 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 1.05 Bn
Mar 29, 2026 1.09 Bn
Dec 28, 2025 1.39 Bn
Sep 28, 2025 1.93 Bn
Jun 29, 2025 1.67 Bn
Mar 30, 2025 4.22 Bn
Dec 29, 2024 3.77 Bn
Sep 29, 2024 4.83 Bn
Jun 30, 2024 4.31 Bn
Mar 31, 2024 3.32 Bn
Dec 31, 2023 2.99 Bn
Oct 1, 2023 2.90 Bn
Jul 2, 2023 2.69 Bn
Apr 2, 2023 4.27 Bn
Jan 1, 2023 2.22 Bn
Oct 2, 2022 1.99 Bn
Jul 3, 2022 1.98 Bn
Apr 3, 2022 1.71 Bn
Jan 2, 2022 1.11 Bn
Oct 3, 2021 2.16 Bn